Cardiac fibrosis is a critical pathophysiological process that occurs with diverse types of
cardiac injury. Lipids are the most important bioenergy substrates for maintaining optimal …

Matrix metalloproteinases (MMPs) are endopeptidases participating in physiological
processes of the brain, maintaining the blood–brain barrier integrity and playing a critical …

Heart failure (HF) is a leading cause of morbidity and mortality particularly in older adults
and patients with multiple metabolic comorbidities. Heart failure with preserved ejection …

Background Myostatin is a negative regulator of skeletal muscle and myocardial mass. The
relationship between myocardial ischemia and scar burden and levels of myostatin has not …

Abnormal cardiac function in the setting of cirrhosis and in the absence of a primary cardiac
disease is known as cirrhotic cardiomyopathy. The pathogenesis of cirrhotic cardiomyopathy …

Heart failure is a clinical syndrome resulting from various cardiovascular diseases of
different aetiologies and pathophysiology. These varying pathologies involve several …

The association of postpartum cardiac reverse remodeling (RR) with urinary proteome,
particularly in pregnant women with cardiovascular (CV) risk factors who show long-term …

Aims Hypertrophic cardiomyopathy (HCM) is characterized by unexplained left ventricular
hypertrophy (LVH) with key pathologic processes including myocardial necrosis, fibrosis …

Salvianolic acid B (Sal B), the main water‐soluble polyphenolic constituent of Danshen, is
noted for its anti‐inflammatory, antioxidant, and antiapoptotic properties, particularly in …

Heart failure (HF) is a growing concern, with significant implications for mortality, morbidity,
and economic sustainability. Traditionally viewed primarily as a hemodynamic disorder …